Accounts Payable

12 Months Ended

Dec. 31, 2015

Accounts Payable Disclosure [Abstract]

Accounts Payable

4. Accounts Payable

 

As of December 31, 2015, Current Liabilities included accounts payable of $54,581, comprised primarily of amounts owed to the Company’s external clinical research organization and public relations firm. By the first week of March 2016, the December 31, 2015 amounts included in accounts payable had been substantially paid. As of December 31, 2014, Current Liabilities included accounts payable of $41,026 and accounts payable – related party of $100,450 for MD Anderson clinical trial hospital expense which had been substantially paid by the first week of May 2015. MD Anderson is no longer a greater than 5% stockholder in the Company. As a result, the Company has consolidated accounts payable with accounts payable – related party on the financial statements beginning in 2015.